M. S. Crcarevska Et Al. , "Definition of formulation design space, in vitro bioactivity and in vivo biodistribution for hydrophilic drug loaded PLGA/PEO-PPO-PEO nanoparticles using OFAT experiments," EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES , vol.49, no.1, pp.65-80, 2013
Crcarevska, M. S. Et Al. 2013. Definition of formulation design space, in vitro bioactivity and in vivo biodistribution for hydrophilic drug loaded PLGA/PEO-PPO-PEO nanoparticles using OFAT experiments. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES , vol.49, no.1 , 65-80.
Crcarevska, M. S., Geskovski, N., Calis, S., Dimchevska, S., Kuzmanovska, S., Petrusevski, G., ... Kajdzanoska, M.(2013). Definition of formulation design space, in vitro bioactivity and in vivo biodistribution for hydrophilic drug loaded PLGA/PEO-PPO-PEO nanoparticles using OFAT experiments. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES , vol.49, no.1, 65-80.
Crcarevska, M. Et Al. "Definition of formulation design space, in vitro bioactivity and in vivo biodistribution for hydrophilic drug loaded PLGA/PEO-PPO-PEO nanoparticles using OFAT experiments," EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES , vol.49, no.1, 65-80, 2013
Crcarevska, M. S. Et Al. "Definition of formulation design space, in vitro bioactivity and in vivo biodistribution for hydrophilic drug loaded PLGA/PEO-PPO-PEO nanoparticles using OFAT experiments." EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES , vol.49, no.1, pp.65-80, 2013
Crcarevska, M. S. Et Al. (2013) . "Definition of formulation design space, in vitro bioactivity and in vivo biodistribution for hydrophilic drug loaded PLGA/PEO-PPO-PEO nanoparticles using OFAT experiments." EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES , vol.49, no.1, pp.65-80.
@article{article, author={M. Simonoska Crcarevska Et Al. }, title={Definition of formulation design space, in vitro bioactivity and in vivo biodistribution for hydrophilic drug loaded PLGA/PEO-PPO-PEO nanoparticles using OFAT experiments}, journal={EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES}, year=2013, pages={65-80} }